Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Sarah Hakam, BS

Sarah Hakam

Ms Hakam is a medical student at Texas A&M’s EnMed program, where she conducts research in nanomedicine drug delivery systems and postpartum mental health, and is actively engaged in mental health advocacy.

Articles by Sarah Hakam, BS

fertility

Burnout and Subfertility in Female Physicians: Examining the Bidirectional Relationship and Emphasizing the Need for Change

BySarah Hakam, BS,Nidal Moukaddam, MD, PhD

July 24th 2025

In this Tales From the Clinic article, explore the hidden struggles of female physicians facing subfertility and burnout, and discover essential strategies for support and intervention.

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
Published: February 3rd 2025 | Updated:

Trending on Psychiatric Times

Closing the Gap in Schizophrenia Care: Insights From the INTEGRATE Guidelines

The Importance of Guidelines

Turning Despair into Joy in Music, Psychiatry, and Society

Fostering Resiliency in Mental Health Professionals: A Strengths-Based, Trauma-Informed Framework

© 2025 MJH Life Sciences^®

All rights reserved.